
---
nice.evidencecategory: 
---

### Evidence Statement CG66HES10
In a further cost-utility analysis published in 2005 intensive blood glucose control with insulin
or sulfonylurea was found to have a cost-effectiveness ratio of 6,028 per QALY gained
compared to conventional glucose (2004 cost year, 3.5%).33

[@Rabinstein_2007]

